In January 1993, Linotar™ Gel  was registered with the South African Medicines Control Council and introduced to the market.  Since then Linotar has also been registered in a variety of countries through a network of marketing partners.

 In the USA, Canada, United Kingdom, Holland, Singapore, Poland and Austria  registrations have been  obtained under the trade name Exorex™. In Australia and New Zealand Linotar and Exorex is available.

Athru-Derm™, a topical  non-steroidal anti-inflammatory with diclofenac sodium as API, and Covarex™, a topical anti-fungal containing miconazole nitrate are currently available only in South Africa.

Additional products are in development and/or under registration. Watch this space!